{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:00:00Z","timestamp":1794711600848,"version":"4.9.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.bone.2010.05.022","type":"journal-article","created":{"date-parts":[[2010,5,25]],"date-time":"2010-05-25T04:18:19Z","timestamp":1274761099000},"page":"493-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases"],"prefix":"10.1016","volume":"47","author":[{"given":"Akimitsu","family":"Miyauchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitsugu","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret R.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2010.05.022_bib1","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1359\/jbmr.1999.14.10.1691","article-title":"Intermittent administration of human parathyroid hormone(1\u201334) prevents immobilization-related bone loss by regulating bone marrow capacity for bone cells in ddY mice","volume":"14","author":"Sakai","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2010.05.022_bib2","doi-asserted-by":"crossref","first-page":"50259","DOI":"10.1074\/jbc.M307444200","article-title":"Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism","volume":"278","author":"Bellido","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2010.05.022_bib3","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2010.05.022_bib4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1532-5415.2006.00695.x","article-title":"Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective","volume":"54","author":"Boonen","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.bone.2010.05.022_bib5","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1001\/archinte.165.15.1762","article-title":"Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass","volume":"165","author":"McClung","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bone.2010.05.022_bib6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s00774-008-0871-3","article-title":"Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose\u2013response study","volume":"26","author":"Miyauchi","year":"2008","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.bone.2010.05.022_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s007740050038","article-title":"Diagnostic criteria of primary osteoporosis","volume":"16","author":"Orimo","year":"1998","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.bone.2010.05.022_bib8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jbmr.5650110510","article-title":"Dual X-ray absorptiometry quality control: comparison of visual examination and process-control charts","volume":"11","author":"Lu","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2010.05.022_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s007740170001","article-title":"Diagnostic criteria for primary osteoporosis: year 2000 revision","volume":"19","author":"Orimo","year":"2001","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.bone.2010.05.022_bib10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2010.05.022_bib11","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1359\/jbmr.080506","article-title":"Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment","volume":"23","author":"Obermayer-Pietsch","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2010.05.022_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1185\/030079905X75096","article-title":"Development of an algorithm for using PINP to monitor treatment of patients with teriparatide","volume":"22","author":"Eastell","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bone.2010.05.022_bib13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bone.2009.07.091","article-title":"Rapid and robust response of biochemical markers of bone formation to teriparatide therapy","volume":"45","author":"Glover","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.05.022_bib14","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2003-1703","article-title":"Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy","volume":"90","author":"Dobnig","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2010.05.022_bib15","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1359\/JBMR.050105","article-title":"Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis","volume":"20","author":"Chen","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2010.05.022_bib16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00198-004-1634-1","article-title":"Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study","volume":"15","author":"Iki","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2010.05.022_bib17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00198-005-2013-2","article-title":"Reduced risk of back pain following teriparatide treatment: a meta-analysis","volume":"17","author":"Nevitt","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2010.05.022_bib18","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s00198-006-0177-z","article-title":"Reduction in the risk of developing back pain persists at least 30months after discontinuation of teriparatide treatment: a meta-analysis","volume":"17","author":"Nevitt","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2010.05.022_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00198-005-2002-5","article-title":"Teriparatide vs. calcitonin in the treatment of Asian postmenopausal women with established osteoporosis","volume":"17","author":"Hwang","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2010.05.022_bib20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1185\/030079906X104768","article-title":"A comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: a 6-month study","volume":"22","author":"Kung","year":"2006","journal-title":"Curr Med Res Opin"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821001255X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821001255X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:34:49Z","timestamp":1757612089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632821001255X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S875632821001255X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2010.05.022","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2010.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}